603398 沐邦高科
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-11.2823.873-27.536-16.0065.250
总资产报酬率 ROA (%)-3.1250.730-10.780-13.1683.857
投入资产回报率 ROIC (%)-6.9442.027-21.405-13.8934.378

边际利润分析
销售毛利率 (%)-3.55117.41619.37331.16931.666
营业利润率 (%)-36.9151.889-22.001-49.5169.957
息税前利润/营业总收入 (%)-33.1844.258-21.270-42.65311.062
净利润/营业总收入 (%)-35.6231.601-24.258-42.8187.959

收益指标分析
经营活动净收益/利润总额(%)80.073127.3929.0933.810127.869
价值变动净收益/利润总额(%)0.00032.9750.175-0.5080.000
营业外收支净额/利润总额(%)0.260-5.3732.581-13.982-3.761

偿债能力分析
流动比率 (X)0.5670.4680.5188.2362.587
速动比率 (X)0.4660.3640.3215.1021.246
资产负债率 (%)62.50883.77377.46011.42724.268
带息债务/全部投入资本 (%)8.52922.39410.0556.421--
股东权益/带息债务 (%)841.975198.802637.1611,444.258427.069
股东权益/负债合计 (%)60.07119.42629.111775.127312.065
利息保障倍数 (X)-8.6681.728-16.190-54.0477.547

营运能力分析
应收账款周转天数 (天)132.66949.46337.50596.4050.000
存货周转天数 (天)119.80597.320143.342311.0120.000